首页> 外国专利> METHOD OF DETERMINING THE METHYLATION SITES PuCGPy REGULATORY REGIONS OF GENES-MARKERS OF COLORECTAL CANCER BY GLAD-PCR-ANALYSIS AND OLIGONUCLEOTIDE PRIMERS AND FLUORESCENT-LABELLED PROBES FOR REALISING SAID METHOD

METHOD OF DETERMINING THE METHYLATION SITES PuCGPy REGULATORY REGIONS OF GENES-MARKERS OF COLORECTAL CANCER BY GLAD-PCR-ANALYSIS AND OLIGONUCLEOTIDE PRIMERS AND FLUORESCENT-LABELLED PROBES FOR REALISING SAID METHOD

机译:GL-PCR分析法测定大肠癌基因标记甲基化部位及寡核苷酸和荧光标记问题的方法

摘要

FIELD: biology.;SUBSTANCE: group of inventions refers to molecular biology and can be used in molecular-genetic diagnosis of oncological diseases. Method involves bio information analysis of previous publications on genes-tumor markers of colorectal cancer and extraction of genes, methylation of PuCGPy sites at regulatory regions of which occurs with high frequency in DNA cells of colorectal cancer, taking into account possibility of detecting gene methylation at early stages of disease and formation of panel of following genes-tumor markers of colorectal cancer: CNRIP1, ELMO1, ESR1, FBN1, RXRg, RYR2, SEPT9b, SOCS3 and UCHL1. It is followed by hydrolysis of highly pure genomic DNA of the analysed biomaterial methyl dependent site-specific DNA-endonuclease GlaI, ligation of universal oligonucleotide adapter with further amplification in real time using genomic primers and probes, complementary sequences of regulatory regions of genes CNRIP1, ELMO1, ESR1, FBN1, RXRg, RYR2, SEPT9b, SOCS3 and UCHL1 in investigated DNA, and hybrid primers, 3'-ends of which is complementary 5'-ends of DNA in specified places hydrolysis GlaI, and remaining part is complementary to adapter sequence. Conclusion on presence of sequence of Pu(5mC)GPy (where 5mC is 5-methylcytosine, Pu - A or G, Py - T or C) in regulatory regions of genes CNRIP1, ELMO1, ESR1, FBN1, RXRg, RYR2, SEPT9b, SOCS3 and UCHL1 is made at onset of fluorescent signal. Adapter sequence is universal oligonucleotide adapter 5'-CCTGCTCTTTCATCG-3'/3'-p-GGACGAGAAAGTAGC-p-5'.;EFFECT: using the inventions enables simplifying and improving accuracy of determining of PuCGPy sites methylation.;3 cl, 1 dwg, 4 tbl, 3 ex
机译:领域:生物学;实体:一组发明涉及分子生物学,可用于肿瘤疾病的分子遗传学诊断。该方法涉及以前关于大肠癌的基因-肿瘤标志物的出版物的生物信息分析和基因的提取,考虑到在大肠癌的DNA细胞中检测其基因甲基化的可能性,PuCGPy位点的调控区域甲基化在大肠癌的DNA细胞中频繁发生。疾病的早​​期阶段和以下结直肠癌基因-肿瘤标志物的组合的形成:CNRIP1,ELMO1,ESR1,FBN1,RXRg,RYR2,SEPT9b,SOCS3和UCHL1。随后是水解所分析的生物材料甲基依赖性位点特异性DNA-核酸内切酶GlaI的高纯度基因组DNA,使用基因组引物和探针连接通用寡核苷酸衔接子并进一步实时扩增,基因CNRIP1调控区的互补序列,被研究的DNA中的ELMO1,ESR1,FBN1,RXRg,RYR2,SEPT9b,SOCS3和UCHL1以及杂合引物,其3'端在特定位置水解DNA的GlaI互补5'端,其余部分与衔接子互补顺序。结论在基因CNRIP1,ELMO1,ESR1,FBN1,RXRg,RYR2,SEPT9b,基因的调控区中存在Pu(5mC)GPy序列(其中5mC是5-甲基胞嘧啶,Pu-A或G,Py-T或C)的序列, SOCS3和UCHL1是在荧光信号开始时产生的。衔接子序列是通用寡核苷酸衔接子5'-CCTGCTCTTTCATCG-3'/ 3'-p-GGACGAGAAAGTAGC-p-5'。效果:使用本发明能够简化和提高测定PuCGPy位点甲基化的准确性; 3 cl,1 dwg ,4汤匙,3前

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号